跳至主要内容
临床试验/NL-OMON49623
NL-OMON49623招募中不适用

Validation of cerebral blood flow-related biomarkers for neurodegenerative disease at an early stage - MemoLife

eurologie - Alzheimer Centrum0 个研究点目标入组 355 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
355

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Healthy volunteers
  • - minimum age of 50 years (which is the minimum age in the Lifelines/ImaLife
  • population);
  • - willingness to cooperate and sign written informed consent;
  • - no prior history of neurologic or significant psychiatric illness.
  • - minimum age of 50 years
  • - diagnosis of MCI or A.D.
  • - People with AD diagnosis: MMSE score between 18 - 26
  • - willingness to cooperate and sign written informed consent;
  • - no prior history of significant psychiatric illness or cardiovascular

排除标准

  • - a diagnosis of vascular disorder;
  • - (other) neurological conditions;
  • - contra-indications for MRI scanning (e.g., metal implants, claustrophobia,
  • cardiac pacemaker, brain surgery);
  • - absence of signed informed consent form;
  • - the refusal to be informed about an unforeseen clinical finding.

研究者

发起方
eurologie - Alzheimer Centrum

相似试验